Part: 12         Session: 145678910111213141516171819202122         Page 417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465 of 999

members were about to resign.

That isn't true. Nobody's resigned in the last six months. Nobody's resigned at all from the Board.

How effective is that Board being at the moment?

Well, I don't think It's a very good board, largely because we have James Watson on it, which is the famous scientist, -- the double helix -- but he taks endlessly and not to any point in the meetings, and many of the basic scientists have no idea of where the clinical frontiers already are, and a lot of the clinicians never really speak up and tell them anything. They never just get brought up short by saying, “Listen, we're this far along. There are certain numbers of drugs, in combination, do cause five year cures, and the percentages of cases are thsese, in these types of cancer we have 8 percent cure in Wilms tumor and 98 percent cures in skin cancers due to drugs. There's every reason to hope we'll get other drug combinations that will work in other types of cancer. This isn't perfect but it's something for now. And a big percentage of our money should certainly go into helping people here and now.”

Nobody ever speaks up and tells them anything.

But at times they do act as a unit, don't they?

They never really decide on how the money should be broken down. They never really get at it. The categories are loose enough so that the staff can shift things from one category